InvestorsHub Logo
Followers 2
Posts 98
Boards Moderated 0
Alias Born 05/07/2014

Re: None

Tuesday, 08/16/2016 12:59:23 PM

Tuesday, August 16, 2016 12:59:23 PM

Post# of 140510
Hargrove needs to resign. He needs to be replaced with someone who will immediately begin to move towards the fastest commercialization possible with the current plan. The last published milestones I grabbed on the titan site showed submission of human clinical trial results to the FDA in 4Q this year with commercialization less than one year from now. In terms of the company's duty to investors, that means they should be at that point by now, not continuing on the quest for academic perfection. That can continue after the product is already at market. It's time to start returning on investments folks. Ditch Hargrove and anyone else who does not understand exactly what duties they took on when they opened this company up to investment. In addition to being cavalier with our money by making these disastrous decisions, they are risking lawsuits and other actions by continuing on this course. This is a publicly-traded company that made representations to the public about its plans and through these induced investment. It's time to make good on those representations. Enough messing around!!!